Cited by 14Advanced Drug Delivery SystemsOcular Surface and Contact LensGlaucoma and retinal disorders

Co-delivery of brinzolamide and timolol from micelles-laden contact lenses: in vitro and in vivo evaluation

Yang, Hongyu, Zhang, Faxing, Fan, Yingzhen, Zhang, Jian, Fang, Ting, Xing, Dandan, Zhen, Yanli, Nie, Zhihao +3 more·2024·Pharmaceutical Research

Abstract

Purpose Traditional eye drops exhibit a modest bioavailability ranging from 1 to 5%, necessitating recurrent application. Thus, a contact lens-based drug delivery system presents substantial benefits. Nonetheless, pharmaceutical agents exhibiting poor solubility may compromise the quintessential characteristics of contact lenses and are, consequently, deemed unsuitable for incorporation. To address this issue, the present study has engineered a novel composite drug delivery system that amalgamates micellar technology with contact lenses, designed specifically for the efficacious conveyance of timolol and brinzolamide.Methods Utilizing mPEG-PCL as the micellar material, this study crafted mPEG-PCL micelles loaded with brinzolamide and timolol through the film hydration technique. The micelle-loaded contact lens was fabricated employing the casting method; a uniform mixture of HEMA and EGDMA with the mPEG-PCL micelles enshrouding brinzolamide and timolol was synthesized. Following the addition of a photoinitiator, 50 μL of the concoction was deposited into a contact lens mold. Subsequently, the assembly was subjected to polymerization under 365 nm ultraviolet light for 35 min, resulting in the formation of the micelle-loaded contact lenses.Results In the present article, we delineate the construction of a micelle-loaded contact lens designed for the administration of brinzolamide and timolol in the treatment of glaucoma. The study characterizes crucial properties of the micelle-loaded contact lenses, such as transmittance and ionic permeability. It was observed that these vital attributes meet the standard requirements for contact lenses. In vitro release studies revealed that timolol and brinzolamide could be gradually liberated over periods of up to 72 and 84 h, respectively. In vivo pharmacodynamic evaluation showed a significant reduction in intraocular pressure and a relative bioavailability of 10.84 times that of commercially available eye drops. In vivo pharmacokinetic evaluation, MRT was significantly increased, and the bioavailability of timolol and brinzolamide was 2.71 and 1.41 times that of eye drops, respectively. Safety assessments, including in vivo irritation, histopathological sections, and protein adsorption studies, were conducted as per established protocols, confirming that the experiments were in compliance with safety standards.In conclusion The manuscript delineates the development of a safe and efficacious micelle-loaded contact lens drug delivery system, which presents a novel therapeutic alternative for the management of glaucoma.

Integrity signals

Registry

Crossref · 10.1007/s11095-024-03672-8

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • mPEG-PCL micelles CLs containing brinzolamide and timolol showed gradual liberation over durations reaching up to 72 h for timolol and 84 h for brinzolamide in vitro.

    “In vitro release studies revealed gradual liberation over durations reaching up to 72 h for timolol and 84 h for brinzolamide respectively.”
  • In vivo pharmacodynamic evaluations demonstrated markedly increased bioavailability and substantial reductions in IOP in the rabbit model for mPEG-PCL micelles CLs.

    “In vivo pharmacodynamic evaluations demonstrated markedly increased bioavailability and substantial reductions in IOP in the rabbit model [163].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yang, H., Zhang, F., Fan, Y., Zhang, J., Fang, T., Xing, D., Zhen, Y., Nie, Z., Liu, Y., Wang, D., & Li, J.
Affiliations
Shenyang Pharmaceutical University (CN)
Corresponding author
  • Wang, Dongkai
  • Li, Ji
Venue
Pharmaceutical Research
Published
2024-02-16
Volume
41
Issue
3
Pages
531-546
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W4392718536
Cited by
14
References
46
Citations by year
2026: 2 · 2025: 9 · 2024: 3
FWCI
2.41
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmaceutical Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Liaoning Provincial Department of Human Resources and Social Security (2020LJC16)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ocular Surface and Contact Lens
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
Keywords
brinzolamide, timolol, glaucoma, intraocular pressure reduction, ocular drug delivery, sustained drug release, bioavailability, pharmacokinetics, photopolymerization, eye irritation, protein adsorption, film hydration, poorly water-soluble drugs, contact lens safety
MeSH terms
Antihypertensive Agents, Contact Lenses, Glaucoma, Humans, Micelles, Ophthalmic Solutions, Polyesters, Polyethylene Glycols, Sulfonamides, Thiazines, Timolol, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review